HCID 23077550, compound → HCID 54705338, compound
Reaction equation
C([O:8][C:9]1[C:10](=[O:34])[C:11]([C:29]2[S:30][CH:31]=[CH:32][N:33]=2)=[CH:12][N:13]2[CH2:18][CH2:17][N:16]([CH2:19][C:20]3[CH:25]=[CH:24][C:23]([F:26])=[C:22]([F:27])[CH:21]=3)[C:15](=[O:28])[C:14]=12)C1C=CC=CC=1>FC(F)(F)C(O)=O>[F:27][C:22]1[CH:21]=[C:20]([CH:25]=[CH:24][C:23]=1[F:26])[CH2:19][N:16]1[CH2:17][CH2:18][N:13]2[CH:12]=[C:11]([C:29]3[S:30][CH:31]=[CH:32][N:33]=3)[C:10](=[O:34])[C:9]([OH:8])=[C:14]2[C:15]1=[O:28]Participants
3
Reactant 1
Product 1
Reagents, catalysts & solvents 1
Procedure
9-Benzyloxy-2-(3,4-difluorobenzyl)-7-(thiazol-2-yl)-3,4-dihydro-2H-pyrido[1,2-a]pyrazine-1,8-dione (35 mg) was dissolved in trifluoroacetic acid (1 ml) and the mixture was stirred at room temperature for 3 hr. Trifluoroacetic acid was evaporated under reduced pressure, toluene was added to the obtained residue and the mixture was concentrated, which operations were performed twice. Ethyl acetate was further added and the obtained solid was collected by filtration to give 2-(3,4-difluorobenzyl)-9-hydroxy-7-(thiazol-2-yl)-3,4-dihydro-2H-pyrido[1,2-a]pyrazine-1,8-dione (14 mg).
Workup
- customTrifluoroacetic acid was evaporated under reduced pressure, toluene
- additionwas added to the obtained residue
- concentrationthe mixture was concentrated
- additionEthyl acetate was further added
- filtrationthe obtained solid was collected by filtration
Sources & evidence
- ORD record
- ord-733699b229c245c08a45bf153522866a
- Source dataset
- uspto-grants-2007_05
- Patent number
- US07211572B2
Reaction notes
Loading…